Gene Expression Profiling of Breast Cancer Cells Predict the Response of Malignant Pleural Effusion

Predicting Non-small Cell Lung Cancer (NSCLC) Lymph Node Metastasis: Integrating Circulating Tumor DNA (ctDNA) Mutation/ Methylation Profiling With Positron Emission Tomography-computed Tomography (PET-CT) Scan

NCT06358222 ·Status: RECRUITING

Detection of EGFR Mutation in Malignant Pleural Effusion of Lung Cancer Patients and Cancer Cell Lines Establishment

NCT00752076 ·Status: UNKNOWN ·Phase: NA

A Multi-center Prospective Observational Biomarker Study on EGFRm+ Non-small Cell Lung Cancer Patients With Leptomeningeal Metastasis

NCT02803619 ·Status: UNKNOWN

Efficacy Study of Clinical Nutrition to Treat Lung Neoplasms And Breast Carcinoma

NCT02603016 ·Status: COMPLETED ·Phase: NA

A Study Assessing Risk Factors for Oral Mucositis/Stomatitis and Ocular Surface Events in NSCLC and Breast Cancer

NCT06686602 ·Status: COMPLETED

Novel Pleural Fluid, Biopsy and Serum Biomarkers for the Investigation of Pleural Effusions

NCT03661801 ·Status: COMPLETED

NGS-based Comprehensive Genomic ctDNA Panel in NSCLC With Immunotherapy

NCT04636047 ·Status: UNKNOWN

Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy of NSCLC Patients in China

NCT03059641 ·Status: COMPLETED

Identifying Early Lung Cancer Cells in Malignant Pleural Effusion Samples From Patients With Primary Lung Cancer

NCT00897143 ·Status: WITHDRAWN

Longitudinal Follow up of Patients With Pleural Effusion

NCT04670562 ·Status: RECRUITING

Multiplex Analysis of Circulating Tumor DNA

NCT03301961 ·Status: UNKNOWN

Impact of Pretreatment Emotional Distress on Survival and the Predictive Role of Peripheral Biomarkers in Immunotherapy Response Among Gastroesophageal and Lung Cancer Patients

NCT06629714 ·Status: COMPLETED

Prospectively Collected Pleural Biopsies for Validation of Malignant Pleural Mesothelioma Prognostic Biomarkers

NCT03683680 ·Status: RECRUITING ·Phase: NA

Cancer Ratio,Pleural Fluid Adenosine Deaminase,Lactate Dehydrogenase, interferonY, Tumor Necrosis Factor,and Interleukins{2,12,18}for Differentiation Between Malignant and Non Malignant Pleural Effusion

NCT05693727 ·Status: NOT_YET_RECRUITING

Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy in ICIs Treated NSCLC Patients

NCT04566432 ·Status: RECRUITING

Association Between Microbiome and the Efficacy and Safety of PD-1/PD-L1 Blockade in Resectable NSCLC

NCT06613308 ·Status: NOT_YET_RECRUITING

Cisplatin for Malignant Pleural Effusion in Patients With Non-small-cell Lung Cancer

NCT02407912 ·Status: UNKNOWN ·Phase: NA

Molecular Subtyping of Extensive Stage Small Cell Lung Cancer and Relevent Clinical Significance

NCT05933863 ·Status: COMPLETED

Pleural Carcinomatosis Tissue Banking

NCT04844827 ·Status: RECRUITING

Biomarkers of Stage III Locally Advanced Unresectable Non-small-cell Lung Cancer

NCT04749407 ·Status: UNKNOWN

Survival Analysis and Prognostic Biomarker Exploration of Postoperative Adjuvant Therapy Patterns in Patients With Non-small Cell Lung Cancer After Neoadjuvant Immunotherapy

NCT07256002 ·Status: ACTIVE_NOT_RECRUITING

Analysis of Driver Gene Mutation in Early Stage Non-small Cell Lung Cancer

NCT04266691 ·Status: COMPLETED

Predictive Gene Profiles and Dynamic Measurement of Treatment Response in Metastatic Non-small Cell Lung Cancer

NCT03512847 ·Status: COMPLETED

Cardiac Substructure Radiation Dose and Early Clinical Monitoring of Stage N2-3 Non-Small Cell Lung Cancer

NCT05252065 ·Status: UNKNOWN

Analysis of Metabonomics for Pleural Effusion

NCT05906823 ·Status: COMPLETED